A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).

Valerie Lee,Ding Ding,Christina Rodriguez,Beth Onners,Amol Narang,Jeffrey J Meyer,Joseph M. Herman,Amy Hacker-Prietz,Richard A. Burkhart,William H. Burns,Jin He,Ana De Jesus Acosta,Rachel B. Klein,Daniel A. Laheru,Dung T. Le,Amy Ryan,Elizabeth A. Sugar,Lei Zheng

A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).

2021

Valerie Lee
Ding Ding
Christina Rodriguez
Beth Onners
Amol Narang
Jeffrey J Meyer
Joseph M. Herman
Amy Hacker-Prietz
Richard A. Burkhart
William H. Burns
Jin He
Ana De Jesus Acosta
Rachel B. Klein
Daniel A. Laheru
Dung T. Le
Amy Ryan
Elizabeth A. Sugar
Lei Zheng

4134Background: Management of locally advanced pancreas cancer (LAPC) standardly involves chemotherapy with consolidative radiation and surgery in selected pts. Checkpoint inhibitors have shown lim...

Keywords:

Medicine
Internal medicine
locally advanced
Phases of clinical research
Chemotherapy
GVAX
Pembrolizumab
Oncology
Cancer
Pancreas
Cyclophosphamide

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations